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Abstract
Background: The bacterium Bacillus subtilis, which is not a natural riboflavin overproducer, has been converted
into an excellent production strain by classical mutagenesis and metabolic engineering. To our knowledge, the
enhancement of riboflavin excretion from the cytoplasm of overproducing cells has not yet been considered as a
target for (further) strain improvement. Here we evaluate the flavin transporter RibM from Streptomyces davawensis
with respect to improvement of a riboflavin production strain.
Results: The gene ribM from S. davawensis, coding for a putative facilitator of riboflavin uptake, was codon
optimized (ribMopt) for expression in B. subtilis. The gene ribMopt was functionally introduced into B. subtilis using
the isopropyl-b-thiogalactopyranoside (IPTG)-inducible expression plasmid pHT01: Northern-blot analysis of total
RNA from IPTG treated recombinant B. subtilis cells revealed a ribMopt specific transcript. Western blot analysis
showed that the his6-tagged heterologous gene product RibM was present in the cytoplasmic membrane.
Expression of ribM in Escherichia coli increased [
14C]riboflavin uptake, which was not affected by the protonophore
carbonyl cyanide m-chlorophenylhydrazone (CCCP). Expression of ribMopt supported growth of a B. subtilis ΔribB::
Erm
r ΔribU::Kan
r double mutant deficient in riboflavin synthesis (ΔribB) and also deficient with respect to riboflavin
uptake (ΔribU). Expression of ribMopt increased roseoflavin (a toxic riboflavin analog produced by S. davawensis)
sensitivity of a B. subtilis ΔribU::Kan
r strain. Riboflavin synthesis by a model riboflavin B. subtilis production strain
overproducing RibM was increased significantly depending on the amount of the inducer IPTG.
Conclusions: The energy independent flavin facilitator RibM could in principle catalyze riboflavin export and thus
may be useful to increase the riboflavin yield in a riboflavin production process using a recombinant RibM
overproducing B. subtilis strain (or any other microorganism).
Background
Riboflavin (vitamin B2) is a direct precursor to the
cofactors flavin mononucleotide (FMN) and flavin ade-
nine dinucleotide (FAD). Riboflavin is synthesized by
plants and many microorganisms; it is not synthesized
by animals [1]. Many Gram-positive bacteria seem to be
capable of acquiring riboflavin from the environment,
whereas most Gram-negative bacteria depend on the
endogenous synthesis of this vitamin [2]. Riboflavin
transporters (uptake systems) have been identified and
characterized in B. subtilis [3], in Lactococcus lactis [4,5]
and in a few other bacteria. Three classes of riboflavin
transporters seem to exist: (1) homologs of ribU of B.
subtilis, (2) homologs of ribM of Corynebacterium gluta-
micum and (3) homologs of impX of Fusobacterium
nucleatum [6]. The latter class has not been functionally
characterized [2]. B. subtilis RibU is part of a modular
multi-subunit riboflavin transporter and belongs to the
recently identified family of energy-coupling factor
(ECF) transporters [7-11]. L. lactis RibU [4] has also
been included in the latter classification, the driving
force behind transport activity was shown to be ATP
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has been crystallized and its three-dimensional structure
has been determined [8]. B. subtilis RibU is a proton-
riboflavin symporter with high affinity for its substrate
(Km = 5-20 nM) [3]. RibU is strikingly different from
the Corynebacterium glutamicum riboflavin transporter
RibM, which was characterized as an energy-indepen-
dent facilitator for riboflavin with much lower affinity
(Km =1 1μM) [3]. RibM from C. glutamicum is similar
(40% at the amino acid level) to RibM (23.7 kDa) from
S. davawensis. The gene for the latter protein is present
in the S. davawensis riboflavin biosynthetic gene cluster
ribBMAH which is controlled by an FMN riboswitch
[12] directly upstream of ribB [13]. S. davawensis is the
only known producer of the riboflavin analog roseofla-
vin, which has antibiotic activity [14]. Highly similar
(> 65% similarity) RibM proteins (all containing five
putative trans membrane domains) are present in other
species of the genus Streptomyces. The gene for the fla-
vin facilitator ribM from S. davawensis was codon opti-
mized for expression in B. subtilis.T h eg e n eribM was
functionally characterized and was found to encode a
transporter for riboflavin and roseoflavin. Finally, ribM
was evaluated as a possible tool to enhance the produc-
tivity of a B. subtilis riboflavin production strain.
Results
Expression of ribM from S. davawensis in E. coli increased
riboflavin uptake
T h ew i l d - t y p eg e n eribM from S. davawensis was
expressed in E. coli using the plasmid pNCO113ribM,
employing an IPTG controlled T5 promotor [15]. E. coli
does not contain an endogenous uptake system for flavins
[16]. Riboflavin import was monitored using [
14C]ribofla-
vin. It was found that expression of ribM resulted in a sig-
nificant increase in the cellular radioactivity shortly after
adding the labelled substrate (Figure 1A) strongly suggest-
ing that ribM codes for a functional flavin transporter.
The uptake activity was 1.5 pmol riboflavin × OD cells
-1
min
-1 in the ribM expressing strain. The control strain
(not containing ribM) showed an uptake activity of 0.04
pmol riboflavin × OD cells
-1 min
-1. Riboflavin uptake
mediated by S. davawensis RibM was only slightly affected
by FAD and the protonophore CCCP (Figure 1B). Roseo-
flavin, FMN and a 10-fold excess of unlabelled riboflavin
apparently reduced [14C]riboflavin uptake suggesting that
roseoflavin and FMN are substrates for RibM. Similar
results were generated in our previous study analysing
RibM from C. glutamicum [3], where it was additionally
shown that riboflavin uptake was not affected by the
absence of glucose or the addition of sodium azide. In
summary, we conclude that RibM from S. davawensis is a
transporter for riboflavin and roseoflavin, and that trans-
port appears to occur independently of metabolic energy.
Introduction of ribM from S. davawensis in B. subtilis
The ribM gene from S. davawensis has a relatively high
G+C-content (72%) and was optimized with respect to the
codon usage of B. subtilis in order to allow efficient het-
erologous expression. The artificial gene was named rib-
Mopt and was inserted into the expression vector pHT01
to give pHT01ribMopt. Expression using pHT01 is based
on the strong s
A-dependent promoter (Pgrac) preceding
the groE operon of B. subtilis which has been converted
into an efficiently controllable (IPTG-inducible) promoter
by addition of the lac operator from E. coli.AB. subtilis
wild-type strain (Marburg 168) and a riboflavin overpro-
ducing B. subtilis strain (BSHP) were transformed with
pHT01ribMopt. From the resulting strains, B. subtilis 168
< pHT01ribMopt > and BSHP < pHT01ribMopt > plasmids
were isolated. DNA sequencing revealed the presence of
the ribMopt gene under control of Pgrac in all strains.
The gene ribMopt from S. davawensis was functionally
expressed in B. subtilis
B. subtilis 168 < pHT01ribMopt >a n dB. subtilis 168 <
pHT01 > (control) were grown to the exponential growth
phase in LB and treated with IPTG (100 μM). Cells were
harvested at different time points after induction (3 h, 6 h
and 9 h) and total RNA was prepared. Northern blot ana-
lysis using a ribMopt specific oligonucleotide probe
revealed, that the heterologous gene ribMopt was expressed
in B. subtilis 168 < pHT01ribMopt >( F i g u r e2 A ) .T h e
0.8 kb transcript was found in IPTG treated cells only.
The strongest signal was observed 3 h after induction
(Figure 2A, lane 4). In this lane an additional band at
1.8 kb appeared, possibly formed by aggregates of not fully
denatured ribMopt transcripts. The data showed that the
ribMopt transcript was present even 9 h after induction (in
the stationary growth phase). Subsequently, cytoplasmic
fractions and membrane fractions of cell-free extracts of
B. subtilis 168 < pHT01ribMopt >a n dB. subtilis 168 <
pHT01 > (control) were subjected to Western blot analy-
sis. The synthesis of his6-tagged RibM was monitored
using anti-penta-his antibodies (Figure 2B). His6-tagged
RibM was found in the membrane fraction of IPTG (100
μM) treated B. subtilis 168 < pHT01ribMopt > only, indi-
cating that RibM was directed to the membranes (Figure
2B, lane 4). The addition of higher amounts of IPTG
(1 mM) did not enhance the amount of heterologous
RibM in recombinant B. subtilis strains (data not shown).
Thus (if not otherwise indicated), in the following experi-
ments, stimulation of RibM synthesis in B. subtilis routi-
nely was carried out using 100 μM IPTG.
Synthesis of RibM in B. subtilis mutants supported growth
and enhanced roseoflavin sensitivity
In the following experiment the B. subtilis double
mutant ΔribB::Erm
r (ribB was deleted and instead an
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Figure 1 Characterization of RibM from Streptomyces davawensis as a riboflavin transporter. (A) The gene ribM from S. davawensis was
overexpressed in E. coli BL21 using the plasmid pNCO113ribM (grey triangles). An Escherichia coli strain containing the empty vector pNCO113
(black circles) served as a control. E. coli strains were grown in riboflavin-free M9 medium. The cells were collected by centrifugation, suspended
in transport buffer (50 mM K2HPO4/KH2PO4, 50 mM MgCl2, pH 7.0) and the experiment was started by adding [
14C]riboflavin to a final
concentration of 1.6 μM. Samples were filtered, washed with water and the radioactivity was determined by liquid scintillation counting. “1O D
cells” means “the amount of cells that when present in 1 ml will lead to an OD600 reading of 1.0”. (B) Uptake experiments were performed as
described for (A) with 2.2 μM[
14C]riboflavin in the presence of a 10-fold excess of riboflavin (ribM+RF), flavin mononucleotide (ribM+FMN), flavin
adenine dinucleotide (ribM+FAD), roseoflavin (ribM+RoF) or carbonyl cyanide m-chlorophenylhydrazone (ribM+CCCP; 130 μM). The uptake
activity in the absence of competitors was 4.8 pmol pmol riboflavin × OD cells
-1 min
-1 (ribM). In the presence of CCCP uptake activity was 4.3
pmol riboflavin × OD cells
-1 min
-1. “1 OD cells” means “the amount of cells that when present in 1 ml will lead to an OD600 reading of 1.0”.
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Page 3 of 10erythromycin resistance gene was introduced) ΔribU::
Kan
r (ribU was deleted and replaced by a kanamycin
resistance gene) was used. This strain carries deletions
in ribB, encoding riboflavin synthase (EC 2.5.1.9) cata-
lyzing the last step of riboflavin biosynthesis [17], and in
ribU, the energy-dependent riboflavin transporter [3].
The double mutant was transformed with pHT01rib-
Mopt or the empty plasmid and both transformants were
compared in growth assays on LB plates. Only the
strains transformed with pHT01ribMopt could grow on
LB, which contains about 0.5 μM riboflavin, or on LB
supplemented with (additional) 0.1 μM riboflavin or
1 μM riboflavin (Figure 3). Upon addition of 10 μM
riboflavin both transformants could grow. Growth of the
control strain, however, was reduced. At 100 μM
riboflavin no difference in growth was observed indicat-
ing that at this concentration the vitamin crosses the
cytoplasmic membrane independently of a dedicated
transport system. Similar experiments were performed
in liquid Spizizen minimal media containing glucose or
sucrose (both at 10 g/L) and 1 μM riboflavin in the pre-
sence or absence of the inducer IPTG. In all experi-
ments, only the pHT01ribMopt containing strains were
able to grow (data not shown). We conclude from these
experiments that RibM was responsible for flavin trans-
port, giving further evidence that RibM from S. dava-
wensis is a functional transporter in B. subtilis.
The mutant strain ΔribU::Kan
r (deficient in flavin
uptake) was transformed with pHT01ribMopt and tested
with respect to roseoflavin sensitivity on LB plates
A.
B.
Figure 2 Monitoring expression of the gene ribM from Streptomyces davawensis in recombinant Bacillus subtilis strains containing the
plasmid pHT01ribMopt. (A) Cell samples (normalized to an OD600 of 1) were taken 3, 6 and 9 h after treatment with IPTG and total RNA was
prepared. Control cells were not treated with the inducer. The level of ribMopt-transcript was assessed by Northern blot analysis using a ribMopt-
specific digoxigenin labelled DNA probe. The predicted size of the ribMopt transcript is 0.8 kb (see arrow). Lanes 1, 6 and 10: B. subtilis 168 <
pHT01 >; Lanes 2, 7 and 11: B. subtilis 168 < pHT01 > induced with 1 mM IPTG; Lanes 3, 8, and 12: B. subtilis 168 < pHT01ribMopt >; Lanes 4, 9
and 13: B. subtilis 168 < pHT01ribMopt > induced with 1 mM IPTG; Lane 5, no sample. (B) After growth in LB and treatment with IPTG B. subtilis
< pHT01ribMopt > cells were collected and cell free extracts were prepared. Cytoplasmic fractions and membrane fractions were subjected to
SDS-PAGE, followed by transfer to a nitrocellulose membrane and analysis with anti-penta-his mouse monoclonal antibodies/goat anti-mouse
IgG alkaline phosphatase (AP)-coupled secondary antibodies. Lane M, protein marker (in kDa); lane 1, B. subtilis < pHT01 > cytoplasmic fraction;
lane 2, B. subtilis 168 < pHT01 > membrane fraction; lane 3, B. subtilis 168 < pHT01ribMopt > cytoplasmic fraction; lane 4, B. subtilis 168 <
pHT01ribMopt > membrane fraction; (C-terminally his6-tagged RibM from Streptomyces davawensis, calculated molecular mass: 24.7 kDa).
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Page 4 of 10containing 100 μM IPTG (Figure 4A). Roseoflavin is a
toxic riboflavin analog. Clearly, the presence of ribM
enhanced roseoflavin transport and thus roseoflavin sen-
sitivity of ΔribU::Kan
r < pHT01ribMopt >a t1 0μM roseo-
flavin. The addition of > 50 μM roseoflavin reduced
growth of the ΔribU::Kan
r control strain containing
empty pHT01, indicating that the flavin (like riboflavin)
is able to permeate over the cytoplasmic membrane with-
out catalysis mediated by a facilitator. Similar experi-
ments were carried out using liquid LB cultures. B.
subtilis ΔribU::Kan
r containing pHT01ribMopt was grown
in the presence of the inducer IPTG and different con-
centrations of roseoflavin (Figure 4B). In LB broth, the
effect of ribMopt was most obvious at 50 μM roseoflavin
where the ribMopt containing strain grew to OD600 of
about 2.5 and the strain containing the empty vector
grew to OD600 of 4.2. A higher concentration of roseofla-
vin (100 μM) inhibited growth of both strains, pointing
towards a transporter independent diffusion of roseofla-
vin (as observed for riboflavin).
RibM enhanced riboflavin production in a high
performance B. subtilis production strain
The high-performance riboflavin production strain BSHP,
which produces about 350 mg/L riboflavin, was trans-
formed with pHT01ribMopt and pHT01. Two transfor-
mant BSHP strains containing pHT01ribMopt (“ribM1”
and “ribM2”) and four transformant strains containing
pHT01 (controls) were isolated and grown in shake flasks
in a medium routinely used for the analysis of the perfor-
mance of industrial riboflavin production strains. For each
strain three different flasks were inoculated and analyzed
(n = 3). The cells were treated with IPTG in order to con-
trol synthesis of RibM. The final cell densities of all cul-
tures were very similar (about OD600 of 4). At the end of
fermentation residual sugar was determined. In all cultures
the carbon source was completely metabolized. The total
amount of riboflavin (mg/L) (intracellular riboflavin and
riboflavin present in the fermentation broth) in the cul-
tures was measured (Figure 5). At 0 μM IPTG the ribofla-
vin concentration was similar in cultures of the
pHT01ribMopt containing strains ribM1 and ribM2 when
compared to the control pHT01 (the results of the three
other control strains were very similar and thus the data
were not included in the figure). Similar results were
obtained at 10 μM IPTG. At 100 μM IPTG and at 1 mM
IPTG, however, a significant increase at the 5% level of sig-
nificance was found. The data revealed that the differences
in productivity were 11% (100 μM IPTG) and 18% (1 mM
IPTG). The latter values were determined by comparing
the average amount of riboflavin synthesized by ribM1
and ribM2 to the amount produced by the control. Sur-
prisingly, at 1 mM IPTG the amount of riboflavin in cul-
tures of the control strain containing the empty plasmid
pHT01 was significantly lower as compared to the values
obtained at 0 μM IPTG, 10 μM IPTG and 100 μM IPTG.
We do not have an explanation for this. As mentioned
above, the control experiment was done with four different
independent transformant strains with similar results. It is
known that reduced growth positively affects the accumu-
lation of metabolites. Growth, however, was very similar in
all cultures (the carbon source was completely metabo-
lized) and therefore a growth limitation cannot explain the
apparent increase of the riboflavin synthesis. All in all our
data suggest that the presence of RibM enhanced ribofla-
vin production under these experimental conditions.
Discussion
Our results suggest that RibM from S. davawensis med-
iates flavin (riboflavin/roseoflavin) translocation via an
without
additional Rf
+ 0.1 M Rf + 1 M Rf + 10 M Rf + 100 M Rf
ribMopt pHT01 ribMopt pHT01 ribMopt pHT01 ribMopt pHT01 ribMopt pHT01
without
additional Rf
+ 0.1 M Rf + 1 M Rf + 10 M Rf + 100 M Rf
ribMopt pHT01 ribMopt pHT01 ribMopt pHT01 ribMopt pHT01 ribMopt pHT01
Figure 3 The overproduction of RibM allowed growth of a ΔribU::Kan
r ΔribB::Erm
r Bacillus subtilis strain. Streaks (top) and drops (bottom,
about 50,000 cells) of B. subtilis ΔribU::Kan
r ΔribB::Erm
r cells expressing ribM from plasmid pHT01ribMopt were applied to LB plates (about 0.5 μM
riboflavin) containing the indicated (additional) amount of riboflavin and 100 μM IPTG. Growth was recorded after incubation for 36 h at 37°C.
As controls, strains were transformed with the empty vector pHT01. Apparently, only the strains transformed with pHT01ribMopt could grow on
culture media (LB) with low amounts of riboflavin.
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Page 5 of 10energy independent facilitated diffusion mechanism. The
probable physiological role of RibM is the acquirement of
riboflavin from the environment. The genes ribBMAH
from S. davawensis form a transcription unit and are
expressed only when riboflavin is limiting in the growth
medium [13]. The genes ribB (riboflavin synthase, alpha-
chain; EC 2.5.1.9), ribA (bifunctional GTP cyclohydrolase
II/3,4-dihydroxy-2-butanone-4-phosphate synthase; EC
3.5.4.25) and ribH (lumazine synthase; EC 2.5.1.9) are
responsible for riboflavin biosynthesis. The fact that ribM
A:
without RoF + 10 M RoF + 50 M RoF + 250 M RoF
ribMopt pHT01 ribMopt pHT01 ribMopt pHT01 ribMopt pHT01
without RoF + 10 M RoF + 50 M RoF + 250 M RoF
ribMopt pHT01 ribMopt pHT01 ribMopt pHT01 ribMopt pHT01
B:
0,00
0,50
1,00
1,50
2,00
2,50
3,00
3,50
4,00
4,50
5,00
5,50
6,00
02468 1 0
time [h]
O
D
6
0
0
pHT01  0 M RoF
pHT01  10 M RoF
pHT01  50 M RoF
pHT01  100 M RoF
ribMopt 0 M RoF
ribMopt 10 M RoF
ribMopt 50 M RoF
ribMopt 100 M RoF
Figure 4 Overproduction of RibM enhanced roseoflavin sensitivity of a ΔribU::Kan
r B. subtilis strain. (A) Streaks (top) and drops (bottom,
about 50,000 cells) of B. subtilis ΔribU::Kan
R cells expressing ribM from plasmid pHT01ribMopt were applied to LB plates containing the indicated
amounts of the toxic riboflavin analog roseoflavin and 100 μM IPTG. Growth was recorded after incubation for 36 h at 37°C. As controls, strains
were transformed with the empty vector pHT01. At 10 μM roseoflavin it was most obvious that the presence of RibM increased roseoflavin
sensitivity due to import of the toxic compound. (B) B. subtilis ΔribU::Kan
R expressing ribM from plasmid pHT01ribMopt was grown in LB broth in
the presence of the indicated amounts of roseoflavin and 100 μM IPTG. Growth was recorded at μ = 600 nm. As controls, ΔribU::Kan
R strains
containing empty pHT01 were analyzed. At 50 μM roseoflavin, the effect of RibM was most obvious (see bracket). Cells (black triangles)
producing RibM imported toxic roseoflavin and consequently grew to an OD600 of about 2.5 only. The control strain (open triangles) was less
affected by roseoflavin and grew to an OD600 of 4.2.
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Page 6 of 10is cotranscribed with the genes ribB, ribA and ribH sug-
gests that a transporter is produced in parallel to the
riboflavin biosynthetic enzymes. This appears not to be
economical. If no riboflavin is present in the cytoplasm,
the corresponding biosynthetic enzymes must be synthe-
sized. The coproduction of a riboflavin transporter, how-
ever, is reasonable only when external riboflavin indeed
is present. In turn, if riboflavin is present in the growth
medium, the production of biosynthetic enzymes appar-
ently constitutes a waste of metabolic energy. Notably, in
the Streptomycetes S. avermitilis, S. coelicolor, S. scabiei
and S. griseus ribBMAH clusters (containing ribM trans-
porter genes) are present as well. It seems that Strepto-
mycetes play it safe with respect to riboflavin supply. If
riboflavin is growth limiting, proteins for transport and
biosynthesis are synthesized in parallel to ensure avail-
ability of the vitamin.
The transport activity and direction of an energy inde-
pendent facilitator depends on the concentration of the
metabolite in the cytoplasm and the surrounding med-
ium, respectively. Thus, RibM in principle may also con-
fer roseoflavin resistance to S. davawensis (by exporting
roseoflavin from the cytoplasm), which naturally pro-
duces this antibiotic in the stationary growth phase. The
export activity of RibM (or other riboflavin transporters)
in principle may also be of importance with respect to
metabolic engineering of riboflavin production strains. In
order to test this idea, ribM was functionally expressed in
a production strain of B. subtilis, an organism, which is
used for the commercial production of riboflavin [18].
The introduction of ribM into a high performance B.
subtilis r i b o f l a v i np r o d u c t i o ns t r a i na p p a r e n t l yi m p r o v e d
riboflavin production. Although the increase was rela-
tively small, for a large scale production process the
improvement may be relevant. We suggest that the
export activity of RibM leads to reduced levels of ribofla-
vin in the cytoplasm possibly enhancing the carbon flux
through the pathway. This may enhance productivity
during the exponential growth phase (when riboflavin
concentration outside is low) or during stationary growth
(when riboflavin levels inside the cells are extremely
high). Wild-type B. subtilis cells rapidly and almost quan-
titatively convert intracellular riboflavin to FMN and
FAD [19], a reaction, which is catalyzed by the bifunc-
tional flavokinase/FAD synthetase RibC. All production
strains have a strongly reduced RibC activity (1%) [20,21].
Thus, production strains contain unusually high amounts
of free riboflavin, which, in principle, might reduce the
activity of the riboflavin biosynthetic enzymes.
The introduction of a protein catalyzing riboflavin
export may also improve current production processes
employing other microorganisms such as Ashbya
0 M IPTG 10 M IPTG 100 M IPTG 1 mM IPTG
Figure 5 Introduction of the heterologous flavin facilitator RibM from Streptomyces davawensis enhanced riboflavin synthesis in the
high-performance riboflavin production strain BSHP. Two BSHP strains containing pHT01ribMopt (designated as ribM1 and ribM2) and one
strain containing pHT01 (control) were grown in shake flasks in the medium used for industrial riboflavin production. For each strain three shake
flask experiments were carried out (n = 3). Different amounts of IPTG were used to induce synthesis of RibM. At the end of fermentation (30 h)
residual sugar and the optical density at μ = 600 nm were measured. In all shake flasks the carbon source was completely metabolized and the
strains had grown to a very similar cell density. For the cultures induced with 100 μM and 1 mM IPTG the t test gave the result that the RibM
containing strains produced more riboflavin (mg/L), which was significant at the 5% level.
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Page 7 of 10gossypii or Candida famata [22]. For A. gossypii inter-
esting physiological studies suggest riboflavin export
across the plasma membrane [23]. To our knowledge
the corresponding exporter has not yet been identified.
Successful examples for strain optimization on the
basis of metabolite export (L-threonine and L-lysine)
have been reported for Corynebacterium glutamicum
[24-26]. Our work is the first to use a similar approach
for optimizing one of the most successful biotechnologi-
cal processes, the commercial synthesis of riboflavin [2].
Conclusions
The gene ribM from S. davawensis encodes a membrane
protein which is able to catalyze the uptake of riboflavin
but also of the antibiotic roseoflavin, a structural riboflavin
analog. The functional expression of ribM in E. coli and
B. subtilis apparently was possible without the cosynthesis
of other protein components. Furthermore, our previous
[3] and our present data data suggest that RibM proteins
are energy independent flavin facilitators. Consequently,
S. davawensis RibM could in principle also catalyze ribo-
flavin export and be useful to increase the riboflavin yield
in a riboflavin production process. Most riboflavin cur-
rently is produced using genetically engineered microor-
ganisms, whereby B. subtilis is an important host. Classic
random mutagenesis and methods of metabolic engineer-
ing have been used in order to optimize B. subtilis for the
production of riboflavin. Most effort was directed at
impairment of regulation of the riboflavin biosynthetic
operon and amplification of the copy number of the struc-
tural genes ribGBAH(T) [2]. However, import of substrates
and export of the product have not yet been considered as
strategies for further improvement. In order to partially fill
this gap, we introduced ribM into a high-performance
B. subtilis riboflavin production strain. We could show
that the gene was actively transcribed and that the gene
product RibM was directed to the cytoplasmic membrane.
Shake flask experiments routinely used to evaluate the
performance of riboflavin overproducing strains suggest
that upon induction with 100 μM IPTG, the amount of
riboflavin at the end of growth indeed is higher as com-
pared to the controls. Possibly, riboflavin transporters
from other microorganisms may even be more useful and
may show even better results.
Methods
Bacterial strains, plasmids and growth conditions
E. coli DH5a was used as a host for gene cloning experi-
ments and was aerobically grown at 37°C on lysogeny
broth (LB) [27,28]. E. coli BL21 [29] was used as a host
for the uptake experiments with [
14C]riboflavin. A
recombinant E. coli BL21 strain overexpressing ribM
from S. davawensis was generated by transformation
using the plasmid pNCO113ribM which was described
earlier [13]. The plasmid pET21 was obtained from
Stratagene (Waldbronn, Germany). If not otherwise indi-
cated B. subtilis was aerobically grown at 37°C in 2 ×
Spizizen’s minimal medium [30] supplemented with
0.02% casamino acids, 2% yeast extract and 10% glucose
or in LB. B. subtilis 168 (trpC2) [31] is a wild-type strain
with respect to riboflavin biosynthesis and uptake and
w a su s e da sac o n t r o l .T h eB. subtilis double mutant
ΔribB::Erm
r ΔribU::Kan
r is auxotrophic for riboflavin and
does not contain a functional riboflavin uptake system
(ribU)[ 3 ] .I tw a sg r o w ni nm e d i as u p p l e m e n t e dw i t h
20 mg/L riboflavin, 1 μg/ml erythromycin and 5 μg/ml
kanamycin. B. subtilis 168 ΔribU::Kan
r [3] was grown
in media supplemented with 5 μg/ml kanamycin. The
B. subtilis high-performance riboflavin production strain
BSHP was constructed by introducing additional copies
of the B. subtilis ribGBAHT genes controlled by strong
constitutive phage promoters (Pspo) into the genome of
B. subtilis strain 3979 [18,32].
Expression of S. davawensis ribM in B. subtilis
B. subtilis strains overproducing RibM (B. subtilis <
pHT01ribMopt >) were generated using the expression
vector pHT01 (Mobitech, Göttingen, Germany) replicating
in Bacillus species from the pUB110 origin [33]. The gene
ribM from S. davawensis was codon-optimized by GEN-
EART (Regensburg, Germany) using overlapping oligonu-
cleotides and PCR. In addition, codons specifying a his6-
tag were introduced at the 3’-end. The gene (ribMopt)( #
FR719838, European Nucleotide Archive) was delivered in
pGA4ribMopt. The latter plasmid was used as a template
for PCR amplification of ribMopt using the modifying oli-
gonucleotides RibMopt fw BamHI (5’-ACA GGA TCC
ATG AAT TGG CTG AAT AGC-3’) and RibMopt rv
AatII (5’-ATT GAC GTC CTA TTA GTG GTG GTG
ATG GTG-3’). The PCR product was purified and
digested with BamHI and AatII to allow cloning in
pHT01. The resulting plasmid pHT01ribMopt was used to
transform B. subtilis using a standard protocol [34].
Expression of ribMopt in B. subtilis was stimulated by add-
ing IPTG in the early exponential growth phase. For selec-
tion of pHT01ribMopt 30 μgm l
-1 chloramphenicol was
added to the growth media. Growth was monitored using
a photometer at μ =6 0 0n m .
Uptake experiments in E. coli
E. coli BL21 cells were grown in M9 minimal medium
[27] supplemented with antibiotics as required. The
growth medium was inoculated to an OD600 of 0.15, and
the cells were grown at 37°C until they reached an OD600
of 0.5. E. coli cells were treated with 0.5 mM IPTG and
grown for 3 h (to an OD600 of 0.8). Cells were harvested,
washed once with ice-cold water and once with transport
buffer (50 mM KH2PO4/K2HPO4,5 0m MM g C l 2 pH
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buffer (10 OD600 ml
-1) and stored on ice. Uptake experi-
ments were performed with 500 μl of cells that were vig-
orously stirred at 30°C. After warming for 2 min, glucose
was added to a final concentration of 1 mM, and the
assay was started by adding [
14C]riboflavin (specific activ-
ity, 5.54 MBq/mg; a generous gift of R. Krämer, Köln,
Germany) to a final concentration of 2 μM. Several ali-
quots were removed at minute intervals, filtered on 0.45-
μm GN-6 membrane filters (Pall, Dreieich, Germany),
washed with an excess of water, and analysed by liquid
scintillation counting. The transport activity was deter-
mined without further additions or after adding carbonyl
cyanide m-chlorophenylhydrazone (CCCP; 130 μM),
unlabeled riboflavin, FMN, FAD or roseoflavin (MP Bio-
medicals, Montreal, Canada) 3 min before addition of the
labeled substrate. The latter assay was done only once.
RNA preparation, Northern (RNA) blotting and
hybridisation
The preparation of total RNA from B. subtilis, the transfer
of RNA to a solid support and the hybridisation to a rib-
Mopt specific digoxigenin-labelled DNA probe was carried
out according to standard procedures [27]. The detection
of the digoxigenin labelled probe was performed as sug-
gested by the supplier of the “DIG DNA Labeling and
Detection Kit” (Roche Diagnostics, Mannheim, Germany).
Preparation of B. subtilis membranes and Western blot
analysis
Stationary phase cultures (50 ml) were harvested by centri-
fugation and washed twice with cold 50 mM Tris-HCl (pH
8.0). Pellets were dissolved in 1 ml TMS buffer (50 mM
Tris-HCl, pH 8.0; 16 mM MgCl2;3 3 %s u c r o s e( w / v ) ;
300 μg/ml lysozyme; 1 mM phenylmethanesulfonylfluor-
ide, PMSF) and incubated for 60 min at 37°C. Protoplasts
were harvested by centrifugation (10 min at 7,500 × g at
4°C). Pellets were suspended in 1 ml lysis buffer (50 mM
Tris-HCl, pH 8.0; 5 mM MgSO4; 2 mM PMSF). Cell free
extracts were produced by sonication (1 min at 60% of the
maximal power and 50% interval) on ice. Membranes
were collected by ultracentrifugation for 30 min at
100,000 × g and washed once with 50 mM Tris-HCl (pH
8.0). Pellets were dissolved in 50 mM Tris-HCl (pH 8.0).
The protein concentration was estimated by the method
of Bradford [35]. The samples were analyzed by SDS-
PAGE on 4-20% gradient polyacrylamide gels using 50 μg
of protein per lane. After transfer to nitrocellulose mem-
branes his6-tagged RibM was immunologically detected
(mouse anti-penta-his primary antibodies/goat anti-mouse
IgG alkaline phosphatase(AP)-coupled secondary antibo-
dies; Novagen, Darmstadt, Germany). AP was detected
with the “AP Detection Reagent Kit” (Novagen) using 3-
bromo-4-chloro-5-indolyl phosphate and nitro blue tetra-
zolium chloride.
Monitoring of riboflavin production
Riboflavin synthesis by B. subtilis i nt h et i m ec o u r s eo f
fermentation was monitored as follows. An aliquot from
the culture containing cells and medium (500 μl) was
combined with 465 μl 4 N NaOH and vigorously mixed
for 1 min. The mixture was neutralized by adding potas-
sium phosphate (1 M pH 8.0) and centrifuged for 5 min
at 13,000 × g at room temperature. Riboflavin in the
supernatant was determined by using a standard proce-
dure employing HPLC [21]. Using the above described
protocol the total amount of riboflavin (intracellular
riboflavin and riboflavin present in the fermentation
broth) was measured. For the statistical analysis of the
data student’s t test was applied comparing two
unknown means based on independent samples.
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